STOCK TITAN

Enanta Pharmaceuticals Inc (ENTA) Revenue by Year

ENTA

Enanta Pharmaceuticals Inc generated $65.3M in revenue in fiscal year 2025. This represents a decrease of 3.4% from the prior fiscal year. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to $65.3M in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Enanta Pharmaceuticals Inc has filed alongside them.

FY2025 annual
Revenue $65.3M
YoY -3.4%
5Y CAGR -11.8%
10Y CAGR -8.6%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ENTA Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Revenue$65.3M$65.3M-3.4%$67.6M-14.6%$79.2M-8.1%$86.2M-11.2%$97.1M-20.7%$122.5M-40.3%$205.2M-0.7%$206.6M+101.0%$102.8M+16.5%$88.3M-45.1%$160.9M+237.0%$47.7M+48.9%$32.1M-23.1%$41.7M-0.4%$41.9M

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

ENTA Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Revenue$14.4M-21.6%$17.2M+15.0%$18.6M+9.8%$15.1M+3.5%$18.3M+1.9%$14.9M-12.5%$17.0M-5.8%$14.6M-22.8%$18.0M-4.9%$17.1M-4.2%$18.0M-23.7%$18.9M-6.8%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Enanta Pharmaceuticals Inc financials

Frequently Asked Questions

What was Enanta Pharmaceuticals Inc's revenue in fiscal year 2025?

Enanta Pharmaceuticals Inc generated $65.3M in revenue in fiscal year 2025.

How fast is Enanta Pharmaceuticals Inc's revenue growing?

Enanta Pharmaceuticals Inc (ENTA) revenue fell by 3.4% year over year, from $67.6M to $65.3M in fiscal year 2025.

What is Enanta Pharmaceuticals Inc's revenue over the last twelve months?

Enanta Pharmaceuticals Inc (ENTA) reported $65.3M in revenue over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Enanta Pharmaceuticals Inc (ENTA) revenue went from $41.9M in fiscal year 2011 to $65.3M in fiscal year 2025.

Enanta Pharmaceuticals Inc (ENTA) reported $14.4M in revenue in Q3 2026. This represents a decrease of 21.6% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Enanta Pharmaceuticals Inc (ENTA) reported on that line in every period on record.